• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, May 11

Strides Arcolab announced that its group company, the Brazil-based Cellofarm Ltda, had inaugurated its sterile injectable facility for penems and penicillins at Compos in Rio de Janeiro. The facility built at $30 million will become a global site for the Rs 760-crore Strides group's growing steriles business.

Cellofarm is one of Brazil's fast growing pharma companies in the hospital and generic segment. Mr Elcemar Almeida, who heads the Latin American operations, said, "The facility is an important expansion strategy for both the Brazilian operations and the Strides group. We are delighted with this major financial and technical commitment the group has made in Brazil and we are confident that the Brazilian operations will continue to play a significant role in the Strides growth strategy."

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Future ATMs will do a lot more than just dispense cash

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line